Structure (Spironolactone 01)
Spironolactone Tablet
Product Images NDC 71335-2366
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 71335-2366). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Spironolactone 02)
This text is showing data related to the comparison between Spironolactone and Placebo. The analysis includes a Log-rank test with a p-value of less than 0.001. The data is presented visually in a timeline format with the durations in months.*
Figure 2 (Spironolactone 03)
This text provides information related to a medical study or trial analyzing the effectiveness of different treatments for a condition like diabetes. The data includes measurements such as creatinine levels, potassium, and the impact of beta blockers. The results are presented graphically, showing the comparison between spironolactone and placebo treatments.*
Label (Lbl713352366)
Each tablet contains Spironolactone, USP 25 mg. Spironolactone Tablets, USP should be stored at 20° to 25°C (68° to 77°F) in a tight, light-resistant container. This medication should be kept out of reach of children and dispensed only as per Rx. For more information, one can visit the website mentioned at the end of the text.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
